ABT-279(676559-83-4)
- Name: ABT-279
- Synonyms:ABT-279;UNII-L094VD806K;
- Molecular Formula:C21H25N5O3
- Molecular Weight:395.45500
- CAS Registry Number:676559-83-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.676559-83-4 ABT 279
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.676559-83-4 ABT 279
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)]
CAS No.676559-83-4 ABT-279
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:ABT-279
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.676559-83-4 ABT 279
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
CAS No.676559-83-4 ABT279
Assay:98% Appearance:Solid powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:ABT279 is a bio-active chemical coumpound. It is used for the treatment of type 2 diabetes. It was developed by Abbvie and was in clinical phase 1 trial, but now it is terminated.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 473727-83-2/(R)-2-hydroxy-N,N-dimethyl-3-(2-(1-(5-methylfuran-2-yl)propylamino)-3,4-dioxocyclobut-1-enylamino)benzamide
- 159633-92-8/MK-677, HCl salt
- 1001350-96-4/BMS-754807
- 728033-96-3/OSI-930
- 692737-80-7/TKI 258
- 857402-63-2/Unii-928Q33Q049
- 871575-98-3/(2R)-[N-(Benzyloxycarbonyl)-D-phenylalanyl-L-prolylamino]-4-methoxybutylboronic acid sodium salt
- 667917-16-0/L-Prolinamide, N-[(phenylmethoxy)carbonyl]-D-phenylalanyl-N-[(1S)-1-borono-4-methoxybutyl]- (9CI)
- 942999-67-9/Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]- ,AcOH salt
- 433937-74-7/2-Azetidinecarboxamide, N-[[4-(aminoiminomethyl)phenyl]methyl]-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-, (2S)-
- 433937-93-0/AZD-0837
- 945667-22-1/Saxagliptin hydrate
- 478644-12-1/GW 813893
- 218298-21-6/Razaxaban
- 201933-41-7/YM-60828
- 850649-61-5/ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)
- 852329-66-9/Dutogliptin
- 813452-18-5/(S)-1-((2S,3S,11bS)-2-amino-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-3-yl)-4-(fluoromethyl)pyrrolidin-2-one
- 887781-62-6/MK-0674
- 676559-83-4/ABT-279
- 956697-53-3/NVP-LDE225
- 782492-17-5/Benzoic acid, 3-[(3R,4S)-3-methyl-1-[(1R,3S)-3-(1-methylethyl)-3-[[6-(trifluoromethyl)-2H-1,3-benzoxazin-3(4H)-yl]carbonyl]cyclopentyl]-4-piperidinyl]-
- 79570-19-7/Brimonidine Tartrate
- 936626-72-1/1-Piperidinemethanamine, N-methyl-
- 36725-26-5/4-(4-acetamidophenyl)-3-methyl-4-oxobutanoic acid
- 501919-59-1/S3I-201
- 315702-99-9/STF-62247
- 99873-43-5/Droxinostat
- 929302-01-2/9-BENZYL-3,9-DIAZA-SPIRO[5.5]UNDECANE-3-CARBOXYLIC ACID TERT-BUTYL ESTER
- 889877-77-4/(R)-2-chloro-7-ethyl-8-isopropyl-7,8-dihydropteridin-6(5H)-one